Medicare Enrolled
Dr. Brian Dicarlo, MD
Hematology & Oncology · San Luis Obispo, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dicarlo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dicarlo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dicarlo
Dr. Brian Dicarlo is a hematology & oncology specialist in San Luis Obispo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dicarlo performed 250,151 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dicarlo received a total of $4,739 from 35 pharmaceutical and/or device companies across 169 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dicarlo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in CA
$4,739 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗250,151
Medicare services
Top 2% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 37,400 | $43 | $213 |
| Nivolumab injection (Opdivo) | 31,384 | $24 | $120 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
30,240 | $38 | $197 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
27,030 | $0 | $10 |
| Denosumab injection (Prolia/Xgeva) | 18,480 | $19 | $94 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
18,400 | $0 | $54 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
17,500 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
16,650 | $0 | $10 |
| Paclitaxel chemotherapy injection | 16,242 | $0 | $1 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
6,290 | $23 | $169 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,204 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,300 | $1 | $95 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,200 | $22 | $222 |
| Anti-nausea injection (ondansetron/Zofran) | 2,632 | $0 | $11 |
| Injection, leucovorin calcium, per 50 mg | 1,900 | $3 | $20 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,500 | $13 | $245 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,155 | $1 | $10 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,118 | $75 | $1,587 |
| Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 1,040 | $11 | $445 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
885 | $114 | $1,071 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
883 | $100 | $858 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
870 | $2 | $17 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
853 | $8 | $58 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
772 | $144 | $960 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
739 | $2 | $259 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 628 | $3 | $669 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
607 | $12 | $120 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
432 | $63 | $436 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
384 | $57 | $620 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
302 | $7 | $487 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
301 | $1 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
272 | $8 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
260 | $65 | $508 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
250 | $28 | $264 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
206 | $25 | $475 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 205 | $134 | $4,038 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
204 | $25 | $550 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
169 | $55 | $382 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
146 | $1 | $15 |
| 5% dextrose/water (500 ml = 1 unit) | 129 | $1 | $15 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
126 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 115 | $177 | $1,360 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
106 | $49 | $447 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
101 | $114 | $1,196 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
100 | $2 | $25 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
97 | $18 | $150 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
80 | $22 | $183 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
72 | $11 | $225 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
49 | $17 | $103 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $13 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $29 | $315 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $122 | $1,085 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $33 | $388 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $98 | $680 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $44 | $354 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.1% high complexity
86.4% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,739
Total received (2018-2024)
Avg $677/year across 7 years
Top 44% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
169
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$421
2023
$625
2022
$638
2021
$939
2020
$18
2019
$393
2018
$1,706
Payments by company (2024)
Genmab U.S., Inc.
$125
ABBVIE INC.
$112
PFIZER INC.
$54
Abbott Laboratories
$46
Merck Sharp & Dohme LLC
$37
E.R. Squibb & Sons, L.L.C.
$25
Medtronic, Inc.
$22
Top 3 companies account for 69.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,258
E.R. Squibb & Sons, L.L.C.
$549
Lilly USA, LLC
$249
AstraZeneca Pharmaceuticals LP
$247
Pharmacyclics LLC, An AbbVie Company
$242
Genentech USA, Inc.
$211
Amgen Inc.
$192
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Janssen Biotech, Inc.
$159
Merck Sharp & Dohme LLC
$131
Pharmacyclics LLC, an AbbVie Company
$131
ABBVIE INC.
$125
Genmab U.S., Inc.
$125
PFIZER INC.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$102
Clovis Oncology, Inc.
$88
Exelixis Inc.
$88
Daiichi Sankyo Inc.
$71
Secura Bio, Inc.
$50
Celgene Corporation
$48
Abbott Laboratories
$46
Medtronic, Inc.
$43
TOLMAR Pharmaceuticals, Inc.
$42
Array BioPharma Inc.
$35
EMD Serono, Inc.
$33
Merck Sharp & Dohme Corporation
$31
SANOFI-AVENTIS U.S. LLC
$29
GENZYME CORPORATION
$22
Dendreon Pharmaceuticals LLC
$21
Regeneron Healthcare Solutions, Inc.
$18
Seattle Genetics, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$16
Gilead Sciences, Inc.
$15
TESARO, Inc.
$14
Puma Biotechnology, Inc.
$14
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Aranesp · BOSULIF · Braftovi · CAMZYOS · CREON · Cabometyx · DARZALEX · ELIGARD · ELREXFIO · EMEND · EMPLICITI · EPKINLY · Epkinly · Erivedge · Erleada · FARYDAK · FASLODEX · FREESTYLE LIBRE 3 · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTELLIS ADAPTIVESTIM · Imbruvica · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · LYNPARZA · MEKINIST · NINLARO · Nerlynx · Neulasta · Nplate · OPDIVO · Onivyde · PROMACTA · PROVENGE · Perjeta · Rubraca · SANDOSTATIN LAR · SYNCHROMEDII · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · VENCLEXTA · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
9
County median income
$93,398
Nearest hospital to ZIP centroid (approximate)
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dicarlo is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dicarlo experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Dicarlo performed 37,400 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dicarlo receive payments from pharmaceutical companies?
Yes. Dr. Dicarlo received a total of $4,739 from 35 companies across 169 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dicarlo's costs compare to other hematology & oncology specialists in San Luis Obispo?
Dr. Dicarlo's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dicarlo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Luis Obispo
Browse hematology & oncology specialists in San Luis Obispo ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology